Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: FAZA PET/MRI Sarcoma [NA]

View source ↗

Summary

This clinical trial update indicates an active-not-recruiting FAZA PET/MRI study in sarcoma, sponsored by the University Health Network in Toronto.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FAZA (fluoroazomycin arabinoside)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Sarcoma | NA | Status: ACTIVE_NOT_RECRUITING